Event and meeting calendar

  • Email
  • Help

Search for all of the European Medicines Agency' events, including workshops, symposia and meetings of the Agency's Management Board and scientific committees.

Committee and Management Board meetings only display from the year 2010.  

Select the events which you wish to view

April 2018

M T W T F S S
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30
Select date to display events/meetings
Year
Month
  • 2018-04-24 - 2018-04-27 : PDCO

    Paediatric Committee (PDCO): 24-27 April 2018

    The Paediatric Committee (PDCO) is the committee that is responsible for assessing the content of paediatric investigation plans, which describe how a medicine should be studied in children, as well as waivers and deferrals.

  • 2018-04-23 - 2018-04-25 : EMA

    The new EudraVigilance system and the electronic reporting of ICSRs in the ISO/ICH E2B(R3) format: hands-on training course

    This hands-on training course covers the functionalities of the new EudraVigilance web application (EVWEB). It includes practical examples for creating, sending and accessing ICSRs in the new ISO/ICH E2B(R3) format. It covers reporting principles in accordance with the guideline on good pharmacovigilance practices (GVP) Module VI 'Management and reporting of adverse reactions to medicinal products' and explanations on how to comply with the EudraVigilance business rules and the EudraVigilance access policy.

  • 2018-04-23 - 2018-04-26 : CHMP

    Committee for Medicinal Products for Human Use (CHMP): 23-26 April 2018

    The Committee for Medicinal Products for Human Use (CHMP) is the committee that is responsible for preparing the Agency's opinions on all questions concerning human medicines.

  • 2018-04-20 - 2018-04-20 : EMA

    Brexit regulatory preparedness for veterinary medicinal products in the centralised procedure

    The European Medicines Agency is holding this meeting to inform veterinary companies on Brexit regulatory preparedness for centrally authorised products and address any specific questions they may have further to the publication of European Commission and EMA questions and answers document and EMA procedural guidance. This event is targeting small and medium enterprises’ needs (SMEs) and is also open to all companies and stakeholders developing veterinary medicinal products.

  • 2018-04-19 - 2018-04-19 : CVMP

    European Medicines Agency veterinary medicines innovation day

    The purpose of the European Medicines Agency (EMA) veterinary medicines innovation day is to raise awareness and promote the support and measures that the Agency has to offer in the area of veterinary medicines innovation. The event is aimed at industry, including micro, small and medium-sized enterprises (SMEs) and veterinary consultants. The information provided will also be beneficial to academia, veterinary healthcare professionals and national competent authorities.

  • 2018-04-18 - 2018-04-20 : CAT

    Committee for Advanced Therapies (CAT): 18-20 April 2018

    The Committee for Advanced Therapies (CAT) is the committee that is responsible for assessing the quality, safety and efficacy of advanced-therapy medicines.

  • 2018-04-17 - 2018-04-19 : COMP

    Committee for Orphan Medicinal Products (COMP): 17-19 April 2018

    The Committee for Orphan Medicinal Products (COMP) is the committee that is responsible for reviewing applications for 'orphan medicinal product designation' for medicines intended for the diagnosis, prevention or treatment of rare diseases.

  • 2018-04-17 - 2018-04-19 : CVMP

    Committee for Medicinal Products for Veterinary Use (CVMP): 17-19 April 2018

    The Committee for Medicinal Products for Veterinary Use (CVMP) is the committee that is responsible for preparing the Agency's opinions on all questions concerning veterinary medicines.

  • 2018-04-17 - 2018-04-18 : EMA

    European Medicines Agency (EMA) Human Scientific Committees' Working Parties with Patients’ and Consumers’ Organisations (PCWP) and Healthcare Professionals’ Organisations (HCPWP) joint meeting

    During the first day of the meeting digital media and health topics will be discussed, including recent learnings and trends around health, social media, real-word evidence and electronic product information. On the second day, PCWP/HCPWP members will have a chance to hear the latest on EMA relocation, clinical data publication policy and implementation of Clinical Trial Regulation; followed by discussion on findings of the survey on “additional monitoring” awareness. Other topics for discussion include EMA-Heads of Medicines Agencies (HMA) collaboration on shortages and availability of medicines and EMA- European network for health technology assessment (EUnetHTA) collaboration on engagement with patients and healthcare professionals in assessment activities.

  • 2018-04-16 - 2018-04-18 : EMA

    The new EudraVigilance system and the electronic reporting of ICSRs in the ISO/ICH E2B(R3) format: hands-on training course

    This hands-on training course covers the functionalities of the new EudraVigilance web application (EVWEB). It includes practical examples for creating, sending and accessing ICSRs in the new ISO/ICH E2B(R3) format. It covers reporting principles in accordance with the guideline on good pharmacovigilance practices (GVP) Module VI 'Management and reporting of adverse reactions to medicinal products' and explanations on how to comply with the EudraVigilance business rules and the EudraVigilance access policy.

  • 2018-04-11 - 2018-04-13 : EMA

    The new EudraVigilance system and the electronic reporting of ICSRs in the ISO/ICH E2B(R3) format: hands-on training course, Prague

    This hands-on training course covers the functionalities of the new EudraVigilance web application (EVWEB). It includes practical examples for creating, sending and accessing ICSRs in the new ISO/ICH E2B(R3) format. It covers reporting principles in accordance with the guideline on good pharmacovigilance practices (GVP) Module VI 'Management and reporting of adverse reactions to medicinal products' and explanations on how to comply with the EudraVigilance business rules and the EudraVigilance access policy.

  • 2018-04-09 - 2018-04-10 : EMA

    eXtended EudraVigilance medicinal product dictionary face-to-face training course, Prague

    The European Medicines Agency (EMA) has prepared this eXtended EudraVigilance medicinal product dictionary (XEVMPD) face-to face training course to facilitate the practical implementation of the requirements including technical aspects and all related procedures on electronic submission of information on medicines by marketing authorisation holders in the European Union (EU) and European Economic Area (EEA) countries outside the EU. The training focuses on explaining the guidance and specifically the mandatory data elements necessary for the electronic submission of information on medicinal products, applying the format of the eXtended EudraVigilance Product Report Message (XEVPRM) and the use of the XEVMPD data entry tool (EVWEB). It includes exercises in the XEVPRM data entry tool (EVWEB) for the electronic submission and maintenance of different types of medicinal products.

  • 2018-04-09 - 2018-04-12 : PRAC

    Pharmacovigilance Risk Assessment Committee (PRAC): 9-12 April 2018

    The Pharmacovigilance Risk Assessment Committee (PRAC) is the committee that is responsible for assessing all aspects of the risk management of medicines for human use.

Related content

Related documents